The recent approval of GLP-1 receptor agonists, including Wegovy and Saxenda, marks a significant development in New Zealand’s fight against obesity. These drugs are now available...
New Zealand has recently made significant strides in combating obesity with the approval of weight loss drugs such as Wegovy and Saxenda. These medications, which belong...